• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Topical Itraconazole Formulations: Unscrupulous Pharmaceutical Companies and Lax Indian Drug Regulators Endangering a Precious Drug.

作者信息

Verma Shyam Bhanushankar, Saraswat Abir, Rao P Narsimha, Dogra Sunil

机构信息

Nirvan Skin Clinic, Makarpura Main Road, Vadodara, Gujarat, India.

Indushree Skin Clinic, Indira Nagar, Lucknow, Uttar Pradesh, India.

出版信息

Indian Dermatol Online J. 2020 Sep 19;11(5):806-811. doi: 10.4103/idoj.IDOJ_659_20. eCollection 2020 Sep-Oct.

DOI:10.4103/idoj.IDOJ_659_20
PMID:33235852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7678552/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbd/7678552/52ad4ad81b7f/IDOJ-11-806-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbd/7678552/b739c7af579a/IDOJ-11-806-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbd/7678552/8708267710a8/IDOJ-11-806-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbd/7678552/14b88b481bd7/IDOJ-11-806-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbd/7678552/52ad4ad81b7f/IDOJ-11-806-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbd/7678552/b739c7af579a/IDOJ-11-806-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbd/7678552/8708267710a8/IDOJ-11-806-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbd/7678552/14b88b481bd7/IDOJ-11-806-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbd/7678552/52ad4ad81b7f/IDOJ-11-806-g004.jpg

相似文献

1
Topical Itraconazole Formulations: Unscrupulous Pharmaceutical Companies and Lax Indian Drug Regulators Endangering a Precious Drug.外用伊曲康唑制剂：无良制药公司与宽松的印度药品监管机构危及一种珍贵药物。
Indian Dermatol Online J. 2020 Sep 19;11(5):806-811. doi: 10.4103/idoj.IDOJ_659_20. eCollection 2020 Sep-Oct.
2
Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations.将难溶性药物转化为亲脂性离子液体可提高基于脂质制剂的口服药物暴露量。
Mol Pharm. 2015 Jun 1;12(6):1980-91. doi: 10.1021/mp500790t. Epub 2015 May 5.
3
Phase behavior of itraconazole-phenol mixtures and its pharmaceutical applications.酮康唑-苯酚混合物的相行为及其药物应用。
Int J Pharm. 2012 Oct 15;436(1-2):652-8. doi: 10.1016/j.ijpharm.2012.07.054. Epub 2012 Jul 31.
4
Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis.用于甲癣局部治疗的更安全无创经甲给药系统的设计与开发。
Drug Dev Ind Pharm. 2015;41(7):1095-9. doi: 10.3109/03639045.2014.931966. Epub 2014 Jul 1.
5
Formulation and characterization study of itraconazole-loaded microparticles.载伊曲康唑微粒的制剂与表征研究
Pharm Dev Technol. 2015 Mar;20(2):153-8. doi: 10.3109/10837450.2013.852572. Epub 2013 Nov 13.
6
Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery.用于眼部给药的载伊曲康唑固体脂质纳米粒的研制与表征
Pharm Dev Technol. 2015 Jun;20(4):458-64. doi: 10.3109/10837450.2014.882935. Epub 2014 Feb 4.
7
Comparison of topical itraconazole 1% with topical natamycin 5% for the treatment of filamentous fungal keratitis.1%外用伊曲康唑与5%外用那他霉素治疗丝状真菌性角膜炎的比较。
Cornea. 2005 May;24(4):449-52. doi: 10.1097/01.ico.0000151539.92865.3e.
8
NanoCluster Itraconazole Formulations Provide a Potential Engineered Drug Particle Approach to Generate Effective Dry Powder Aerosols.纳米簇伊曲康唑制剂提供了一种潜在的工程化药物颗粒方法来制备有效的干粉气雾剂。
J Aerosol Med Pulm Drug Deliv. 2015 Oct;28(5):341-52. doi: 10.1089/jamp.2014.1155. Epub 2015 Feb 13.
9
Formulation and evaluation of itraconazole via liquid crystal for topical delivery system.通过液晶用于局部给药系统的伊曲康唑的制剂与评价
J Pharm Biomed Anal. 2001 Oct;26(3):387-99. doi: 10.1016/s0731-7085(01)00414-9.
10
D-optimal experimental approach for designing topical microemulsion of itraconazole: Characterization and evaluation of antifungal efficacy against a standardized Tinea pedis infection model in Wistar rats.伊曲康唑局部微乳剂设计的D-最优实验方法：对Wistar大鼠标准化足癣感染模型的抗真菌功效表征与评价
Eur J Pharm Sci. 2015 Jan 25;67:97-112. doi: 10.1016/j.ejps.2014.10.014. Epub 2014 Nov 4.

本文引用的文献

1
A prospective study on patterns of topical steroids self-use in dermatophytoses and determinants predictive of cutaneous side effects.一项关于皮肤癣菌病局部类固醇自我使用模式及皮肤副作用预测因素的前瞻性研究。
Dermatol Ther. 2020 Jul;33(4):e13633. doi: 10.1111/dth.13633. Epub 2020 Jun 23.
2
Alarming India-wide phenomenon of antifungal resistance in dermatophytes: A multicentre study.令人震惊的印度范围内的皮肤真菌抗药性现象：一项多中心研究。
Mycoses. 2020 Jul;63(7):717-728. doi: 10.1111/myc.13091. Epub 2020 May 4.
3
MIC and Upper Limit of Wild-Type Distribution for 13 Antifungal Agents against a Trichophyton mentagrophytes-Trichophyton interdigitale Complex of Indian Origin.
针对源自印度的须癣毛癣菌-红色毛癣菌复合群的 13 种抗真菌药物的 MIC 和野生型分布上限。
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.01964-19.
4
Over-the-counter medicines: Global perspective and Indian scenario.非处方药：全球视角与印度情况
J Postgrad Med. 2020 Jan-Mar;66(1):28-34. doi: 10.4103/jpgm.JPGM_381_19.
5
Determination of antifungal minimum inhibitory concentration and its clinical correlation among treatment failure cases of dermatophytosis.皮肤癣菌病治疗失败病例中抗真菌药物最低抑菌浓度的测定及其临床相关性
J Family Med Prim Care. 2019 Aug 28;8(8):2577-2581. doi: 10.4103/jfmpc.jfmpc_483_19. eCollection 2019 Aug.
6
Topical Itraconazole for the Treatment of Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome or High-Frequency Basal Cell Carcinomas: A Phase 2, Open-Label, Placebo-Controlled Trial.外用伊曲康唑治疗基底细胞痣综合征或高频基底细胞癌患者的基底细胞癌：一项2期开放标签、安慰剂对照试验。
JAMA Dermatol. 2019 Sep 1;155(9):1078-1080. doi: 10.1001/jamadermatol.2019.1541.
7
Sale of medicines by Registered Medical Practitioners at their clinics: Legal and ethical issues.注册医生在其诊所售药：法律与伦理问题
Indian J Psychiatry. 2019 Apr;61(Suppl 4):S786-S790. doi: 10.4103/psychiatry.IndianJPsychiatry_89_19.
8
Characteristics of Skin Deposition of Itraconazole Solubilized in Cream Formulation.伊曲康唑在乳膏制剂中溶解后的皮肤沉积特征。
Pharmaceutics. 2019 Apr 22;11(4):195. doi: 10.3390/pharmaceutics11040195.
9
The current Indian epidemic of superficial dermatophytosis due to Trichophyton mentagrophytes-A molecular study.当前印度由于须毛癣菌引起的浅部皮肤癣菌病流行——一项分子研究。
Mycoses. 2019 Apr;62(4):336-356. doi: 10.1111/myc.12878. Epub 2019 Feb 20.
10
"Over the Internet" sale of prescription-level topical corticosteroids and dilemma of dermatologists.
Int J Dermatol. 2018 Nov;57(11):1403-1407. doi: 10.1111/ijd.14207. Epub 2018 Sep 6.